Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program
- 1 November 2009
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 27 (11) , 931-945
Abstract
Capacity is limited in the developing world to conduct cost-effectiveness analysis (CEA) of health interventions. In Thailand, there have been concerted efforts to promote evidence-based policy...Keywords
This publication has 18 references indexed in Scilit:
- Making sensible rationing: the use of economic evidence and the need for methodological standards.2008
- Policy making and roles of health technology assessment.2008
- The need for guidelines and the use of economic evidence in decision-making in Thailand: lessons learnt from the development of the national list of essential drugs.2008
- Health technology assessment in Canada: diversity and evolutionMedical Journal of Australia, 2007
- A Systematic Review of Economic Evaluation Literature in ThailandPharmacoEconomics, 2007
- Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluationInternational Journal of Technology Assessment in Health Care, 2005
- What Is Next for Pharmacoeconomics and Outcomes Research in Asia?Value in Health, 2004
- Health sector regulation in Thailand: recent progress and the future agendaHealth Policy, 2003
- Using evidence to inform health policy: case studyBMJ, 2001
- Strategies to enhance the use of health systems research for health sector reformTropical Medicine & International Health, 1999